EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson’s disease models

Matthew G Williamson, Marta Madureira iD, William McGuinness, Rachel Heon-Roberts, Elliot D Mock, Kalina Naidoo, Kaitlyn M L Cramb, Maria-Claudia Caiazza iD, Ana B Malpartida, Martha Lavelle, Katrina Savory, Stewart W Humble und 5 weitere

Human Molecular Genetics · 05.09.2023 · 32 (18) · 2808-2821

DOI: 10.1093/hmg/ddad102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 29.06.2023. Verfasst von Matthew G Williamson und 16 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Parkinson's Disease Centre and Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QU, UK. Hauptthemen laut MEDLINE: Parkinson Disease, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Clarendon Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in the Leucine-Rich Repeat Kinase 2 (LRRK2) gene have been identified as one of the most common genetic causes of Parkinson’s disease (PD). The LRRK2 PD-associated mutations LRRK2G2019S and LRRK2R1441C, located in the kinase domain and in the ROC-COR domain, respectively, have been demonstrated to impair mitochondrial function. Here, we sought to further our understanding of mitochondrial health and mitophagy by integrating data from LRRK2R1441C rat primary cortical and human induced pluripotent stem cell-derived dopamine (iPSC-DA) neuronal cultures as models of PD. We found that LRRK2R1441C neurons exhibit decreased mitochondrial membrane potential, impaired mitochondrial function and decreased basal mitophagy levels. Mitochondrial morphology was altered in LRRK2R1441C iPSC-DA but not in cortical neuronal cultures or aged striatal tissue, indicating a cell-type-specific phenotype. Additionally, LRRK2R1441C but not LRRK2G2019S neurons demonstrated decreased levels of the mitophagy marker pS65Ub in response to mitochondrial damage, which could disrupt degradation of damaged mitochondria. This impaired mitophagy activation and mitochondrial function were not corrected by the LRRK2 inhibitor MLi-2 in LRRK2R1441C iPSC-DA neuronal cultures. Furthermore, we demonstrate LRRK2 interaction with MIRO1, a protein necessary to stabilize and to anchor mitochondria for transport, occurs at mitochondria, in a genotype-independent manner. Despite this, we found that degradation of MIRO1 was impaired in LRRK2R1441C cultures upon induced mitochondrial damage, suggesting a divergent mechanism from the LRRK2G2019S mutation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseInduced Pluripotent Stem CellsHumansRatsAnimalsAgedLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MitophagyMutationMitochondria

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, human

Autor:innen und Institutionen

  • Oxford Parkinson's Disease Centre and Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QU, UK.
  • Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford OX1 3QU, UK.
  • ICBAS, Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, Rua Jorge de Viterbo Ferreira, 228, Porto 4050-313, Portugal.
  • National Institute of Neurological Disorders and Stroke, National Institutes of Health , Bethesda, MD, 20892, USA.
  • Oxford Drug Discovery Institute, Centre of Medicines Discovery, University of Oxford, NDM Research Building, Old Road Campus, Oxford OX3 7FZ, UK.

ORCID-Profile: Marta Madureira, Maria-Claudia Caiazza

Förderung

  • Medical Research Council
  • Wellcome Trust
  • Clarendon Fund
  • St. John’s College
  • Canadian Centennial Scholarship Fund
  • Natural Sciences and Engineering Research Council of Canada
  • Dutch Research Council
  • undação para a Ciência e Tecnologia (FCT), Portugal

Zitieren

APA

Williamson, M. G., Madureira, M., McGuinness, W., Heon-Roberts, R., Mock, E. D., Naidoo, K., Cramb, K. M. L., Caiazza, M. C., Malpartida, A. B., Lavelle, M., Savory, K., Humble, S. W., Patterson, R., Davis, J. B., Connor-Robson, N., Ryan, B. J., & Wade-Martins, R. (2023). Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson’s disease models. Human Molecular Genetics, 32(18), 2808-2821. https://doi.org/10.1093/hmg/ddad102

Vancouver

Williamson MG, Madureira M, McGuinness W, Heon-Roberts R, Mock ED, Naidoo K, et al. Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson’s disease models. Human Molecular Genetics. 2023;32(18):2808-2821. doi:10.1093/hmg/ddad102

BibTeX
@article{Williamson2023,
  author = {Williamson, Matthew G and Madureira, Marta and McGuinness, William and Heon-Roberts, Rachel and Mock, Elliot D and Naidoo, Kalina and Cramb, Kaitlyn M L and Caiazza, Maria-Claudia and Malpartida, Ana B and Lavelle, Martha and Savory, Katrina and Humble, Stewart W and Patterson, Ryan and Davis, John B and Connor-Robson, Natalie and Ryan, Brent J and Wade-Martins, Richard},
  title = {Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson’s disease models},
  journal = {Human Molecular Genetics},
  year = {2023},
  volume = {32},
  number = {18},
  pages = {2808--2821},
  doi = {10.1093/hmg/ddad102}
}
Kostenlos starten →